Oppenheimer analyst Noah Kaye lowered the firm’s price target on Itron (ITRI) to $145 from $155 and keeps an Outperform rating on the shares. The firm notes shares traded down sharply Thursday after Itron beat Q3 consensus estimates, while guiding the Q4 sales and bookings outlook lower than the Street estimate. As investors digest an incrementally slower hardware sales cycle related to utility regulatory/planning uncertainty, along with lapping $1/share discrete tax benefits into FY26, Oppenheimer anticipates investor caution until signals of increased project flow rates present.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI:
